Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice.

Abstract:

BACKGROUND:Although K14E6 transgenic mice develop spontaneous tumors of the skin epithelium, no spontaneous reproductive tract malignancies arise, unless the transgenic mice were treated chronically with 17beta-estradiol. These findings suggest that E6 performs critical functions in normal adult cervix and skin, highlighting the need to define E6-controlled transcriptional programs in these tissues. METHODS:We evaluated the expression profile of 14,000 genes in skin or cervix from young K14E6 transgenic mice compared with nontransgenic. To identify differentially expressed genes a linear model was implemented using R and the LIMMA package. Two criteria were used to select the set of relevant genes. First a set of genes with a Log-odds > or = 3 were selected. Then, a hierarchical search of genes was based on Log Fold Changes. RESULTS:Microarray analysis identified a total of 676 and 1154 genes that were significantly up and down-regulated, respectively, in skin from K14E6 transgenic mice. On the other hand, in the cervix from K14E6 transgenic mice we found that only 97 and 252 genes were significantly up and down-regulated, respectively. One of the most affected processes in the skin from K14E6 transgenic mice was the cell cycle. We also found that skin from transgenic mice showed down-regulation of pro-apoptotic genes and genes related to the immune response. In the cervix of K14E6 transgenic mice, we could not find affected any gene related to the cell cycle and apoptosis pathways but did observe alterations in the expression of immune response genes. Pathways such as angiogenesis, cell junction and epidermis development, also were altered in their gene expression profiles in both tissues. CONCLUSION:Expression of the HPV16 E6 oncoprotein in our model alters expression of genes that fell into several functional groups providing insights into pathways by which E6 deregulate cell cycle progression, apoptosis, the host resistance to infection and immune function, providing new opportunities for early diagnostic markers and therapeutic drug targets.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Mendoza-Villanueva D,Diaz-Chavez J,Uribe-Figueroa L,Rangel-Escareão C,Hidalgo-Miranda A,March-Mifsut S,Jimenez-Sanchez G,Lambert P,Gariglio P

doi

10.1186/1471-2407-8-347

subject

Has Abstract

pub_date

2008-11-26 00:00:00

pages

347

issn

1471-2407

pii

1471-2407-8-347

journal_volume

8

pub_type

杂志文章
  • A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.

    abstract:BACKGROUND:CST6 promoter is highly methylated in cancer, and its detection can provide important prognostic information in breast cancer patients. The aim of our study was to develop a Methylation-Sensitive High Resolution Melting Analysis (MS-HRMA) assay for the investigation of CST6 promoter methylation. METHODS:We ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-486

    authors: Dimitrakopoulos L,Vorkas PA,Georgoulias V,Lianidou ES

    更新日期:2012-10-22 00:00:00

  • Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.

    abstract:BACKGROUND:The need for novel biomarkers that could aid in non-small cell lung cancer (NSCLC) detection, together with the relevance of Matrix Metalloproteases (MMPs) -1, -2, -7, -9 and -10 in lung tumorigenesis, prompted us to assess the diagnostic usefulness of these MMPs and the Tissue Inhibitor of Metalloproteinase...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3842-z

    authors: Blanco-Prieto S,Barcia-Castro L,Páez de la Cadena M,Rodríguez-Berrocal FJ,Vázquez-Iglesias L,Botana-Rial MI,Fernández-Villar A,De Chiara L

    更新日期:2017-12-05 00:00:00

  • MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.

    abstract:BACKGROUND:MicroRNAs (miRNAs) are short, non-coding RNAs (~22 nt) that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. Although miR-196a has been implicated in several other cancers, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present st...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-348

    authors: Liu XH,Lu KH,Wang KM,Sun M,Zhang EB,Yang JS,Yin DD,Liu ZL,Zhou J,Liu ZJ,De W,Wang ZX

    更新日期:2012-08-09 00:00:00

  • Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.

    abstract:BACKGROUND:Expression of Nodal, a member of the TGF-β superfamily, is commonly absent in differentiated tissues, while its re-expression occurs in a variety of human malignancy. However, little is known about its involvement in ovarian tumorigenesis. Herein, we focused on the functional roles of Nodal in ovarian endome...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5539-y

    authors: Miura R,Yokoi A,Matsumoto T,Oguri Y,Hashimura M,Tochimoto M,Kajita S,Saegusa M

    更新日期:2019-04-03 00:00:00

  • Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.

    abstract:BACKGROUND:There has been a sharp rise in the incidence of human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC) in many countries. Patients with HPV-positive OPSCC have a more favorable prognosis compared with HPV-negative OPSCC, leading to investigation and adoption of de-escalation trea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6266-0

    authors: Nopmaneepaisarn T,Tangjaturonrasme N,Rawangban W,Vinayanuwattikun C,Keelawat S,Bychkov A

    更新日期:2019-11-06 00:00:00

  • Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.

    abstract:BACKGROUND:Breast cancer is the most common invasive cancer among women. Currently, there are only a few models used for therapy selection, and they are often poor predictors of therapeutic response or take months to set up and assay. In this report, we introduce a microfluidic OrganoPlate® platform for extracellular m...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3709-3

    authors: Lanz HL,Saleh A,Kramer B,Cairns J,Ng CP,Yu J,Trietsch SJ,Hankemeier T,Joore J,Vulto P,Weinshilboum R,Wang L

    更新日期:2017-11-02 00:00:00

  • Clinical study of systemic chemotherapy combined with bronchoscopic interventional cryotherapy in the treatment of lung cancer.

    abstract:BACKGROUND:This study is designed to investigate the clinical value of systemic chemotherapy combined with bronchoscopic interventional cryotherapy in the treatment of lung cancer. METHODS:A total of 412 lung cancer patients admitted to Cangzhou People's Hospital from March 2018 to March 2020 were collected and divide...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07444-6

    authors: Xu F,Song J,Xu B,Wang J,Mao J,Liu H,Li X,Deng A

    更新日期:2020-11-11 00:00:00

  • ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.

    abstract:BACKGROUND:The nucleoside analog, ARC (NSC 188491) is a recently characterized transcriptional inhibitor that selectively kills cancer cells and has the ability to perturb angiogenesis in vitro. In this study, the mechanism of action of ARC was further investigated by comparing in vitro and in vivo activity with other ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-63

    authors: Stockwin LH,Yu SX,Stotler H,Hollingshead MG,Newton DL

    更新日期:2009-02-20 00:00:00

  • Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation.

    abstract:BACKGROUND:An emerging immunotherapy is infusion of tumor infiltrating Lymphocytes (TIL), with objective response rates of around 50% versus 19% for ipilimumab. As an Advanced Therapeutic Medicinal Products (ATMP), TIL is highly personalized and complex therapy. It requests substantial upfront investments from the hosp...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4788-5

    authors: Retèl VP,Steuten LMG,Geukes Foppen MH,Mewes JC,Lindenberg MA,Haanen JBAG,van Harten WH

    更新日期:2018-09-15 00:00:00

  • Does hair dye use really increase the risk of prostate cancer?

    abstract::Recently, Shu-Yu Tai et al. reported that personal hair dye use increased risk of prostate cancer with a dose-response effect. Although hair dyes were identified as carcinogenic in animals and increased risk of some cancers among hairdressers, the existing epidemiological data did not support that personal hair dye us...

    journal_title:BMC cancer

    pub_type: 评论,杂志文章

    doi:10.1186/s12885-017-3656-z

    authors: Jiann BP

    更新日期:2017-11-07 00:00:00

  • The XRCC 1 DNA repair gene modifies the environmental risk of stomach cancer: a hospital-based matched case-control study.

    abstract:BACKGROUND:Previous studies have found that polymorphisms of the DNA repair gene X-ray repair cross-complementing group 1(XRCC1) and environmental factors are both associated with an increased risk of stomach cancer, but no study has reported on the potential additive effect of these factors among Thai people. The aim ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3675-9

    authors: Putthanachote N,Promthet S,Hurst C,Suwanrungruang K,Chopjitt P,Wiangnon S,Chen SL,Yen AM,Chen TH

    更新日期:2017-10-11 00:00:00

  • Resolution of severe hyponatraemia is associated with improved survival in patients with cancer.

    abstract:BACKGROUND:Hyponatraemia is a common finding in patients with cancer, and has been shown to be associated with poor prognosis in different settings. We have analysed the impact of severe hyponatraemia in patients with cancer. METHODS:A retrospective review of all patients admitted to a specialist cancer hospital with ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1156-6

    authors: Balachandran K,Okines A,Gunapala R,Morganstein D,Popat S

    更新日期:2015-03-22 00:00:00

  • The A818-6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer.

    abstract:BACKGROUND:The human pancreatic cancer cell line A818-6 can be grown in vitro either as a highly malignant, undifferentiated monolayer (ML) or as three-dimensional (3D) single layer hollow spheres (HS) simulating a benign, highly differentiated, duct-like pancreatic epithelial structure. This characteristic allowing A8...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06773-w

    authors: Tawfik D,Zaccagnino A,Bernt A,Szczepanowski M,Klapper W,Schwab A,Kalthoff H,Trauzold A

    更新日期:2020-03-30 00:00:00

  • Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.

    abstract:BACKGROUND:There is international interest in risk-stratification of breast screening programmes to allow women at higher risk to benefit from more frequent screening and chemoprevention. Risk-stratification also identifies women at low-risk who could be screened less frequently, as the harms of breast screening may ou...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07158-9

    authors: McWilliams L,Woof VG,Donnelly LS,Howell A,Evans DG,French DP

    更新日期:2020-07-22 00:00:00

  • Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

    abstract:BACKGROUND:Metronomic chemotherapy is considered an anti-angiogenic therapy that involves chronic administration of low-dose chemotherapy at regular short intervals. We investigated the optimal metronomic dose of oral vinorelbine when given as monotherapy in patients with metastatic cancer. METHODS:Patients with recur...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/1471-2407-13-263

    authors: Briasoulis E,Aravantinos G,Kouvatseas G,Pappas P,Biziota E,Sainis I,Makatsoris T,Varthalitis I,Xanthakis I,Vassias A,Klouvas G,Boukovinas I,Fountzilas G,Syrigos KN,Kalofonos H,Samantas E

    更新日期:2013-05-29 00:00:00

  • Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis.

    abstract:BACKGROUND:cMyc and p27 are key genes implicated in carcinogenesis. Whether polymorphisms in these genes affect breast cancer risk or prognosis is still unclear. In this study, we focus on a rare non-synonymous polymorphism in cMyc (N11S) and a common polymorphism in p27 (V109G) and determine their role in risk and pro...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-99

    authors: Figueiredo JC,Knight JA,Cho S,Savas S,Onay UV,Briollais L,Goodwin PJ,McLaughlin JR,Andrulis IL,Ozcelik H

    更新日期:2007-06-14 00:00:00

  • Dietary restriction during the treatment of cancer: results of a systematic scoping review.

    abstract:BACKGROUND:Diets that restrict energy or macronutrient intake (e.g. fasting/ketogenic diets (KDs)) may selectively protect non-tumour cells during cancer treatment. Previous reviews have focused on a subset of dietary restrictions (DR) or have not performed systematic searches. We conducted a systematic scoping review ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5931-7

    authors: Shingler E,Perry R,Mitchell A,England C,Perks C,Herbert G,Ness A,Atkinson C

    更新日期:2019-08-15 00:00:00

  • ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).

    abstract:BACKGROUND:Recent randomized controlled trials comparing neoadjuvant chemoradiation plus surgery or perioperative chemotherapy plus surgery with surgery alone showed significant survival benefits for combined modality treatment of patients with localized esophageal adenocarcinoma. However, head-to-head comparisons of n...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-016-2564-y

    authors: Hoeppner J,Lordick F,Brunner T,Glatz T,Bronsert P,Röthling N,Schmoor C,Lorenz D,Ell C,Hopt UT,Siewert JR

    更新日期:2016-07-19 00:00:00

  • Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma.

    abstract:BACKGROUND:Several studies have described an increased cyclooxygenase-2 (COX-2) expression in pancreatic cancer, but the role of COX-2 in tumour development and progression is not clear. The aim of the present study was to examine expression of COX-2 in cancer cells and stromal cells in pancreatic cancer specimens, and...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-413

    authors: Pomianowska E,Sandnes D,Grzyb K,Schjølberg AR,Aasrum M,Tveteraas IH,Tjomsland V,Christoffersen T,Gladhaug IP

    更新日期:2014-06-09 00:00:00

  • Relevance of internal time and circadian robustness for cancer patients.

    abstract:BACKGROUND:Adequate circadian timing of cancer treatment schedules (chronotherapy) can enhance tolerance and efficacy several-fold in experimental and clinical situations. However, the optimal timing varies according to sex, genetic background and lifestyle. Here, we compute the individual phase of the Circadian Timing...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2319-9

    authors: Ortiz-Tudela E,Innominato PF,Rol MA,Lévi F,Madrid JA

    更新日期:2016-04-21 00:00:00

  • Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?

    abstract:BACKGROUND:The use of computerized systems to support evidence-based practice is commonplace in contemporary medicine. Despite the prolific use of electronic support systems there has been relatively little research on the uptake of web-based systems in the oncology setting. Our objective was to examine the uptake of a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-112

    authors: Langton JM,Pesa N,Rushton S,Ward RL,Pearson SA

    更新日期:2013-03-12 00:00:00

  • Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia.

    abstract:BACKGROUND:We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. METHODS:NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up to the end of 2004. Ri...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-231

    authors: Yu XQ,Chen WH,O'Connell DL

    更新日期:2010-05-24 00:00:00

  • FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes.

    abstract:BACKGROUND:FAM3B/PANDER is a novel cytokine-like protein that induces apoptosis in insulin-secreting beta-cells. Since in silico data revealed that FAM3B can be expressed in prostate tumors, we evaluated the putative role of this cytokine in prostate tumor progression. METHODS:FAM3B expression was analyzed by quantita...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3950-9

    authors: Maciel-Silva P,Caldeira I,de Assis Santos I,Carreira ACO,Siqueira FR,Antonioli E,Goldberg AC,Belizário JE,Garay-Malpartida HM

    更新日期:2018-01-22 00:00:00

  • The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.

    abstract:BACKGROUND:Neuroendocrine tumors (NETs) of the esophagus are extremely rare, and few cases have been reported worldwide. Thus, a comprehensive nationwide study is needed to understand the characteristics of and treatment strategy for esophageal NETs. METHODS:We collected data on esophageal NET patients from 25 hospita...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-569

    authors: Lee CG,Lim YJ,Park SJ,Jang BI,Choi SR,Kim JK,Kim YT,Cho JY,Yang CH,Chun HJ,Song SY,Neuroendocrine tumor study group.

    更新日期:2014-08-07 00:00:00

  • Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.

    abstract:BACKGROUND:Mounting evidence shows that microRNA-34a (miR-34a) is involved in cancer prognosis. Therefore, we summarize the predictive role of miR-34a for survival in patients with gastrointestinal cancers (GICs). METHODS:All eligible studies were found by searching PubMed, Web of Science and EMBASE, and survival resu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07751-y

    authors: Chen YL,Liu XL,Li L

    更新日期:2021-01-14 00:00:00

  • ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly.

    abstract:BACKGROUND:ZFP36 is an mRNA binding protein that exerts anti-tumor activity in glioblastoma by triggering cell death, associated to an increase in the stability of the kinase RIP1. METHODS:We used cell death assays, size exclusion chromatography, Co-Immunoprecipitation, shRNA lentivectors and glioma neural stem cells ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1388-5

    authors: Selmi T,Alecci C,dell' Aquila M,Montorsi L,Martello A,Guizzetti F,Volpi N,Parenti S,Ferrari S,Salomoni P,Grande A,Zanocco-Marani T

    更新日期:2015-05-06 00:00:00

  • Numerical analysis of intracellular amino acid profiles of breast cancer cells with K-Ras or PI3K mutation in response to kinase inhibitors.

    abstract:BACKGROUND:Various efforts to understand the relationship between biological information and disease have been done using many different types of highthroughput data such as genomics and metabolomics. However, information obtained from previous studies was not satisfactory, implying that new direction of studies is in ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4972-7

    authors: Jeong J,Seo K,Kim ES

    更新日期:2018-11-13 00:00:00

  • ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.

    abstract:BACKGROUND:Breast cancer is one of the leading causes of death in women worldwide. Fast growth is the important character of breast cancer, which makes sure the subsequent metastasize and invasion breast cancer. Golgi related genes GOLPH3 has been reported to regulate many kinds of cancers proliferation. However, its u...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4031-4

    authors: Song Q,Chen Q,Wang Q,Yang L,Lv D,Jin G,Liu J,Li B,Fei X

    更新日期:2018-03-09 00:00:00

  • The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer.

    abstract:BACKGROUND:The preoperative prognostic nutritional index (PNI) has been reported to correlate with the prognosis in patents with various carcinomas. However, the prognostic significance of the postoperative PNI is unknown. The aim of this study was to evaluate the prognostic significance of the postoperative PNI in pat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1537-x

    authors: Shibutani M,Maeda K,Nagahara H,Ohtani H,Iseki Y,Ikeya T,Sugano K,Hirakawa K

    更新日期:2015-07-16 00:00:00

  • Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO).

    abstract:OBJECTIVES:The present study aims to evaluate long-term side-effects and outcomes and confirm prognostic factors after stereotactic body radiotherapy (SBRT) of pulmonary lesions. This is the first work that combines the investigated data from patient charts and patient-reported outcome (PRO) up to 14 years after therap...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6635-8

    authors: Kessel KA,Grosser RCE,Kraus KM,Hoffmann H,Oechsner M,Combs SE

    更新日期:2020-05-19 00:00:00